Xolair set to put Houston onthe biotechnology map
The US Food and Drug Administration approved the asthma drug Xolair last Friday, giving Houston what it needs to become a hub of biotechnology, industry experts
The US Food and Drug Administration approved the asthma drug Xolair last Friday, giving Houston what it needs to become a hub of biotechnology, industry experts